CRVS- Corvus Pharmaceuticals, Inc.

Name: Corvus Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

CRVS sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Compare Health Care sector insider flows →

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Miller Richard A Md	1.19M	$14.38M	-
CFO	Lea Leiv	400.0K	-	-
Other	Jones William Benton	400.0K	-	-
Other	Arcara Jeffrey	100.0K	-	-
Dir	Chan Andrew C.	30.0K	-	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 11, 2026	Moore David Scott	Director	Buy	21,700	$11.53	$250,235.72	New	-	-
May 18, 2026	Miller Richard A Md64	President And CEO	Buy	6,932	$12.04	$83,453.32	+0.6%	-	-
Jun 27, 2025	Orbimed Advisors LLC66	Director, 10% Owner	Sell	1,176,332	$4.16	$4,891,894.26	-14.1%	+69.9%	+246.8%
Jun 27, 2025	Thompson Peter A.63	Director, 10% Owner	Sell	1,176,332	$4.16	$4,891,894.26	-14.1%	+69.9%	+246.8%
May 6, 2024	Jones William Benton	See Remarks	Buy	20,000	$1.73	$34,624.00	+15.0%	+47.6%	+75.4%
May 6, 2024	Miller Richard A Md64	President And CEO	Buy	577,634	$1.73	$999,999.98	New	+47.6%	+75.4%
May 15, 2023	Grais Linda	Director	Buy	10,000	$2.45	$24,500.00	New	-14.2%	-13.1%
Dec 20, 2022	Jones William Benton	See Remarks	Buy	20,000	$0.79	$15,800.00	+17.6%	-12.2%	+100.0%
Dec 14, 2022	Miller Richard A Md64	President And CEO	Buy	60,000	$0.75	$44,827.00	+4.2%	-14.8%	+94.9%
Dec 14, 2022	Lea Leiv	Chief Financial Officer	Buy	34,000	$0.75	$25,639.00	+34.3%	-14.8%	+94.9%

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC